Catalonia’s healthcare purchasing consortium has launched a €1 billion dynamic procurement framework allowing qualified medicine suppliers to join throughout its term.
The Catalan Health and Social Care Consortium (Consorci de Salut i Social de Catalunya, CSC) has launched a dynamic purchasing system for medicines with an estimated procurement value of €1 billion. The consortium announced the scheme on 21 October after opening supplier admission in September.
More than 20 public healthcare centres had joined the framework and approximately 80 companies had been admitted when CSC announced it. The initial operating period runs until September 2028, with possible extensions taking the total term to four years.
The system covers generic, reference, biosimilar and hybrid medicines authorised and marketed in Spain. Unlike conventional tenders with a fixed supplier pool, qualifying manufacturers or distributors may apply to join during the framework’s operation. Participating centres can then arrange specific competitions to meet their needs, generally by active substance.
Price is not necessarily the sole award criterion. Individual contracts may also include medicine traceability, identifiable unit doses and environmental features. The scheme therefore provides a continuing procurement framework with competition among suppliers as the market changes.
CSC has operated other dynamic purchasing arrangements for medicines and medical products since 2019. The October development broadens the model’s scope and scale, including generic medicines alongside other categories, rather than introducing dynamic procurement for the first time.
The estimated €1 billion is the value of the purchasing framework, not expenditure already committed or evidence of savings achieved. Its effects will depend on individual contracts, supplier participation and the purchasing choices of the participating centres.
Source: Catalan Health and Social Care Consortium
Link: Impulsem una licitació de medicaments de 1.000 milions d’euros per millorar l’eficiència del sistema públic de salut (We launch a €1 billion medicines tender to improve the efficiency of the public healthcare system)
Date: 21 October 2026
Please accept {{cookieConsents}} cookies to view this content